Premium
The value of human menopausal gonadotropin treatment in patients with unexplained infertility
Author(s) -
Gürgan T.,
Kişnişçi H.,
Yarali H.,
Aksu T.,
Zeyneloĝlu H.,
Develioĝlu O.
Publication year - 1991
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(91)90666-s
Subject(s) - medicine , unexplained infertility , infertility , gonadotropin , hmg coa reductase , menotropins , gynecology , ovulation , ovulation induction , obstetrics , pregnancy , hormone , biochemistry , genetics , reductase , biology , enzyme , chemistry
The role of multiple ovulation with human menopausal gonadotropin (HMG) in the treatment of unexplained infertility is evaluated. Of a total 73 patients with unexplained infertility, 39 received four cycles of HMG, whereas, 34 were left untreated. Eight (20.5%) women conceived during HMG treatment, in comparison to only 1 (2.9%) in the control group (P < 0.05). This study gives further credit to the value of HMG treatment for unexplained infertility.